Rheumatology (Oxford, England)
Journal
Overview
publication venue for
-
Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T cell therapy..
65.
2026
-
Higher comorbidities associated with less improvement in disease activity in early RA: results from CATCH cohort..
64.
2025
-
Loneliness and social isolation among middle-aged and older adults with SLE: a single centre cross-sectional study..
64.
2025
-
Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study..
64.
2025
-
Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases..
64.
2025
-
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")..
64.
2025
-
Incidence of checkpoint inhibitor-associated inflammatory arthritis, immunomodulation and mortality in cancer patients on immunotherapy: a retrospective cohort study..
64.
2025
-
Comparison of two frailty definitions in women with systemic lupus erythematosus..
63.
2024
-
Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry..
63.
2024
-
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry..
63.
2024
-
Inflammatory arthritis complicating mogamulizumab treatment of Sézary syndrome..
63.
2024
-
Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure..
62.
2023
-
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization..
62.
2023
-
Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program..
62.
2023
-
Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab..
62.
2023
-
Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations..
62.
2023
-
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial..
62.
2023
-
Clinical integration of patient-reported outcome measures to enhance the care of patients with SLE: a multi-centre prospective cohort study..
61.
2022
-
Prevalence of frailty in patients with polymyalgia rheumatica and association with health-related quality of life, cognition and sarcopenia..
61.
2022
-
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension..
61.
2022
-
Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis..
61.
2022
-
Axonal dysfunction is associated with interferon-γ levels in childhood-onset systemic lupus erythematosus: a multivoxel magnetic resonance spectroscopy study..
61.
2022
-
Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry..
61.
2022
-
The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey..
61.
2022
-
Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study..
61.
2022
-
Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking..
60.
2021
-
US rheumatologists' beliefs and knowledge about biosimilars: a survey..
60.
2021
-
Unique Sjögren's syndrome patient subsets defined by molecular features..
59.
2020
-
Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus..
59.
2020
-
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts..
57.
2018
-
Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists..
57.
2018
-
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients..
57.
2018
-
The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices..
57.
2018
-
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis..
57.
2018
-
The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies..
57.
2018
-
Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis..
56.
2017
-
The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis..
56.
2017
-
Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis..
56.
2017
-
Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension..
56.
2016
-
Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment..
55.
2016
-
Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort..
55.
2016
-
A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis..
55.
2016
-
Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis..
54.
2014
-
Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort..
53.
2014
-
Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study..
53.
2014
-
Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort..
53.
2013
-
A parallel group cohort to determine the measurement properties of an early inflammatory arthritis detection tool..
52.
2013
-
Low prevalence of coeliac disease in patients with systemic sclerosis: a cross-sectional study of a registry cohort..
52.
2013
-
IL-7Rαlow memory CD8+ T cells are significantly elevated in patients with systemic lupus erythematosus..
51.
2012
-
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort..
51.
2012
-
Fibrocyte activation in rheumatoid arthritis..
49.
2009
-
Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers..
47 Suppl 3.
2008
-
Chronic inflammation modulates ghrelin levels in humans and rats..
43.
2003
-
Acupuncture for chronic low back pain in older patients: a randomized, controlled trial..
42.
2003
-
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome..
41.
2002
-
Comment on 'ANA-positive versus ANA-negative antiphospholipid antibody-positive patients: results from the APS ACTION Registry'. Reply..
64.
2025
-
Ultraviolet light exposure from manicures in cutaneous lupus erythematosus..
61.
2022
-
Corrigendum to: Patient and Rheumatologist Perspectives on Tapering DMARDs in Rheumatoid Arthritis: A Qualitative Study..
60.
2021
-
Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials..
60.
2021
-
Corrigendum to: Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis..
60.
2021
-
Renal arteriovenous fistula in Behçet's disease..
60.
2021
-
Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis..
60.
2021
-
Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus..
59.
2020
-
Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis: reply..
59.
2020
-
More than meets the eye: IgG4-related disease presenting as isolated interstitial lung disease..
56.
2017
-
Comment on: Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse events..
60.
2021
-
Has TNF inhibitor use decreased the need for total hip and total knee replacement for patients with RA?.
58.
2019
-
Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis..
58.
2019
-
Management of rheumatoid arthritis..
53.
2014
-
The times they are a changin'..
52.
2013
-
Introduction: new trends in pregnancy and rheumatic diseases..
47 Suppl 3.
2008
-
A genomic meta-analysis of clinical variables and their association with intrinsic molecular subsets in systemic sclerosis.
2022
-
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials.
2020
-
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis.
2019
-
Management of perioperative tumour necrosis factor α inhibitors in rheumatoid arthritis patients undergoing arthroplasty: a systematic review and meta-analysis.
2015
-
Cardiac arrhythmias and conduction defects in systemic sclerosis.
2013
-
The new ACR/EULAR classification criteria for RA: how are the new criteria performing in the clinic?
2012
-
The new ACR/EULAR remission criteria: rationale for developing new criteria for remission.
2012
-
Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative.
2012
-
Pregnancy and reproduction in autoimmune rheumatic diseases.
2010
-
Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review.
2010
-
Challenges of lupus pregnancies.
2008
-
Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs.
2008
-
Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.
2007
-
Towards a pro-inflammatory and immunomodulatory emerging role of leptin.
2006
-
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
2003
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)